Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations.
Travelling to Basel, Switzerland for Informa Connect / EBD Group’s BIO-Europe Spring, taking place at the Messe Congress Center between the 20th and 22nd March, pharmaphorum listened to par
In the pharma industry, key opinion leaders (KOLs) can significantly influence the consumer purchasing decision, as they have invested time and research to be recognised by their peers as e
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho